Is Orlistat the Same as Wegovy? What the Differences Actually Mean for You

Step 1: understand what each medicine actually does in your body

Orlistat works locally, inside your digestive tract. It attaches to enzymes called lipases and prevents them from breaking down fat in food. Because undigested fat cannot be absorbed, roughly a third of the fat you eat passes through your system undigested. This means the calories it contributes are simply not taken in. The effect is real but contingent on what you eat: if your diet is already low in fat, orlistat has less to act on. The NHS medicines information for orlistat covers the detail well if you want the full picture.

Wegovy takes a fundamentally different route. Semaglutide is a synthetic version of a gut hormone called GLP-1, which is released naturally after eating. By activating GLP-1 receptors in the brain and gut, it curbs appetite, extends the feeling of fullness after a meal, and slows the movement of food through the stomach. The result is that many people eat less without feeling deprived. Our page on how semaglutide works covers the mechanism in more depth.

These are genuinely different approaches to the same problem. One targets the absorption of a specific macronutrient; the other changes the hormonal signals that drive hunger and satiety. Knowing which approach suits your physiology, your diet, and your health history is the kind of thing a prescriber works out with you rather than something a comparison article can settle.

Step 2: weigh up the clinical evidence side by side

A question our prescribers hear most weeks, particularly from people who have previously tried orlistat, is whether switching to an injectable medicine would actually produce better results. The honest answer is that the trial evidence does suggest a meaningful difference in average weight loss.

In the STEP 1 trial, published in the New England Journal of Medicine, adults without diabetes taking semaglutide 2.4 mg lost an average of around 15% of body weight over 68 weeks. The MHRA has since approved a higher 7.2 mg maintenance dose, with trials reporting average losses approaching 20.7% over 72 weeks. Orlistat trials typically show average weight losses in the range of 5–10% over similar periods, with outcomes heavily influenced by dietary adherence. Neither figure is a guarantee, and both medicines require lifestyle changes alongside them.

NICE's recommendation for semaglutide (Wegovy) under guidance TA875 applies within specialist weight management services for eligible adults; the eligibility thresholds and conditions are described on our Wegovy overview page. If you are comparing costs as well as effectiveness, our Wegovy price comparison page explains what UK private prescriptions typically include.

Step 3: consider side effects and practical differences

The side-effect profiles are quite different, and that matters for day-to-day life. Orlistat's most common effects are gastrointestinal and directly tied to fat intake: oily or loose stools, urgency, and flatulence are frequently reported, particularly when meals are high in fat. Sticking to a low-fat diet largely avoids them, which is by design rather than coincidence.

Wegovy carries a GI side-effect profile too, but the character is different: nausea, vomiting, constipation, and indigestion are most noticeable when treatment starts or after a dose increase, and they tend to ease over the first few weeks as your body adjusts. The NHS medicines pages for tirzepatide and semaglutide both outline what to watch for in plain terms. If you are wondering whether combining the two medicines is ever appropriate, our page on taking orlistat with Wegovy covers that specifically.

Practically, the two treatments differ in administration and storage. Orlistat is a capsule taken up to three times a day with meals containing fat; Wegovy is a once-weekly injection that requires refrigeration between 2–8°C. Travel, routine, and personal preference all factor into which is manageable long-term.

Step 4: know where to go next if you want clinical guidance

Orlistat and Wegovy are not interchangeable, and neither is obviously the right choice for every person. Your weight history, any existing health conditions, medicines you already take, and how you relate to food all feed into that decision. Our page on medicines that interact with Wegovy is worth reading before a consultation if you are already taking other treatments.

It is also worth separating Wegovy from other semaglutide products. Ozempic, for example, is also semaglutide but is licensed for type 2 diabetes management rather than weight loss, our page on whether Wegovy and Ozempic are the same explains the distinction clearly. And if you are curious about the broader semaglutide family, this page addresses that overlap.

If Wegovy sounds like something you would like to explore properly, the right starting point is a clinical consultation. At nume, a GPhC-registered Independent Prescriber reads your answers the same day, not software. You can start your free consultation here, there is no obligation and no fee for the assessment itself.